Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1999. Start Trial.
Date Value
October 06, 2026 4.405
October 05, 2026 4.636
October 02, 2026 4.643
October 01, 2026 4.583
September 30, 2026 4.576
September 29, 2026 4.513
September 28, 2026 4.625
September 25, 2026 4.640
September 24, 2026 4.697
September 23, 2026 4.940
September 22, 2026 5.194
September 21, 2026 5.130
September 18, 2026 5.217
September 17, 2026 5.369
September 16, 2026 5.139
September 15, 2026 5.065
September 14, 2026 5.270
September 11, 2026 5.075
September 10, 2026 5.035
September 09, 2026 5.027
September 08, 2026 5.181
September 04, 2026 5.082
September 03, 2026 4.999
September 02, 2026 5.034
September 01, 2026 5.060
Date Value
August 31, 2026 5.088
August 28, 2026 5.007
August 27, 2026 5.304
August 26, 2026 5.463
August 25, 2026 5.594
August 24, 2026 5.627
August 21, 2026 5.931
August 20, 2026 5.761
August 19, 2026 6.026
August 18, 2026 6.212
August 17, 2026 6.189
August 14, 2026 6.100
August 13, 2026 5.940
August 12, 2026 5.900
August 11, 2026 5.751
August 10, 2026 5.776
August 07, 2026 5.429
August 06, 2026 5.407
August 05, 2026 5.339
August 04, 2026 5.391
August 03, 2026 5.208
July 31, 2026 5.302
July 30, 2026 5.376
July 29, 2026 4.838
July 28, 2026 4.969

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.5429
Exicure, Inc. 7.046
Century Therapeutics, Inc. 1.026
Absci Corp. 7.158
Celularity, Inc. --

Price to Book Value Related Metrics

Price 80.18
Earnings Yield -3.07%
Market Cap 4.897B